Elizabeth Arden, Inc. is a global beauty products company with a portfolio of fragrance, skin care and cosmetics brands. The Company's segments include North America and International. The Company's North America segment sells its portfolio of owned, licensed and distributed brands, including the Elizabeth Arden products, to retailers, mass retailers and distributors in the United States, Canada and Puerto Rico, and also includes its direct to consumer business, which consists of its Elizabeth Arden branded retail outlet stores and its e-commerce business in North America. The Company's North America segment also sells Elizabeth Arden products through the Red Door Spa beauty salons and spas. The Company's International segment sells its portfolio of owned and licensed brands, including its Elizabeth Arden products, to perfumeries, boutiques, department stores, travel retail outlets and distributors in approximately 120 countries outside of North America.
Industry, Sector and Symbol:
- Sector: Non-Cyclical Consumer Goods & Services
- Industry: Cosmetics & Perfumes
- Sub-Industry: Personal Products
- Symbol: NASDAQ:RDEN
- CUSIP: 28660G10
- Web: www.elizabetharden.com/
Average Prices:- 50 Day Moving Avg: $13.93
- 200 Day Moving Avg: $10.50
- 52 Week Range: $5.02 - $14.14
P/E:- Trailing P/E Ratio: N/A
- Foreward P/E Ratio: 139.90
- P/E Growth: 0.00
Profitability:- Net Margins: -11.89%
- Return on Equity: -135.03%
- Return on Assets: -11.66%
Debt:- Debt-to-Equity Ratio: 5.93%
- Current Ratio: 1.59%
- Quick Ratio: 0.69%
Misc:- Average Volume: 989,170 shs.
- Beta: 1.35
Frequently Asked Questions for Elizabeth Arden (NASDAQ:RDEN)
What is Elizabeth Arden's stock symbol?
Elizabeth Arden trades on the NASDAQ under the ticker symbol "RDEN."
How were Elizabeth Arden's earnings last quarter?
Elizabeth Arden, Inc. (NASDAQ:RDEN) released its quarterly earnings results on Wednesday, August, 10th. The company reported ($0.58) EPS for the quarter, topping the Thomson Reuters' consensus estimate of ($0.78) by $0.20. The company earned $192.70 million during the quarter, compared to analyst estimates of $193.75 million. Elizabeth Arden had a negative return on equity of 135.03% and a negative net margin of 11.89%. View Elizabeth Arden's Earnings History.
Where is Elizabeth Arden's stock going? Where will Elizabeth Arden's stock price be in 2017?
1 brokers have issued 12 month target prices for Elizabeth Arden's stock. Their predictions range from $14.00 to $14.00. On average, they expect Elizabeth Arden's stock price to reach $14.00 in the next twelve months. View Analyst Ratings for Elizabeth Arden.
Who are some of Elizabeth Arden's key competitors?
Some companies that are related to Elizabeth Arden include British American Tobacco PLC (BTI), British American Tobacco PLC (BTI), Unilever plc (ULVR), British American Tobacco plc (BATS), Ambev SA (ABEV), Diageo plc (DGE), Reckitt Benckiser Group Plc (RB), Imperial Brands PLC (IMB), Associated British Foods plc (ABF), Tesco PLC (TSCO), Kerry Group Public Ltd Co (KYGA), Coca Cola HBC AG (CCH), US Foods Holding Corp (USFD), WM Morrison Supermarkets PLC (MRW), J Sainsbury plc (SBRY), Booker Group Plc (BOK), Tate & Lyle PLC (TATE) and Fevertree Drinks PLC (FEVR).
How do I buy Elizabeth Arden stock?
Shares of Elizabeth Arden can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Elizabeth Arden's stock price today?
One share of Elizabeth Arden stock can currently be purchased for approximately $13.99.
MarketBeat Community Rating for Elizabeth Arden (NASDAQ RDEN)MarketBeat's community ratings are surveys of what our community members think about Elizabeth Arden and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Consensus Ratings for Elizabeth Arden (NASDAQ:RDEN) (How are Consensus Ratings Calculated?) MarketBeat calculates consensus ratings using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings. Each stock's consensus rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
| Ratings Breakdown: | 1 Hold Rating |
| Consensus Rating: | Hold (Score: 2.00) |
| Consensus Price Target: | $14.00 (0.07% upside) |
Analysts' Ratings History for Elizabeth Arden (NASDAQ:RDEN)
Show:
| Date | Firm | Action | Rating | Price Target | Impact on Share Price | Details |
|---|
| 9/25/2016 | B. Riley | Reiterated Rating | Neutral | $14.00 | N/A |  |
| 6/8/2016 | Imperial Capital | Reiterated Rating | Outperform | $14.00 | N/A | |
(Data available from 7/26/2015 forward)
Earnings History for Elizabeth Arden (NASDAQ:RDEN)Earnings History by Quarter for Elizabeth Arden (NASDAQ RDEN)| Date | Quarter | Consensus Estimate | Actual EPS | Revenue Estimate | Actual Revenue | Release Link | Conference Call | Details |
|---|
| 8/10/2016 | Q416 | ($0.78) | ($0.58) | $193.75 million | $192.70 million | View | Listen | |
| 5/5/2016 | Q316 | ($0.74) | ($0.59) | $190.33 million | $191.90 million | View | N/A | |
| 2/4/2016 | Q216 | $0.60 | $0.10 | $344.58 million | $316.20 million | View | N/A | |
| 11/4/2015 | Q116 | ($0.17) | ($0.18) | $267.88 million | $266.00 million | View | N/A | |
| 8/6/2015 | Q415 | ($0.65) | ($1.57) | $188.70 million | $175.50 million | View | N/A | |
| 5/7/2015 | Q315 | ($0.47) | ($0.86) | $194.48 million | $191.70 million | View | Listen | |
| 2/5/2015 | Q2 | $0.62 | $0.28 | $370.16 million | $333.60 million | View | Listen | |
| 10/30/2014 | Q1 | ($0.53) | ($0.43) | $275.10 million | $270.40 million | View | Listen | |
| 8/19/2014 | Q414 | ($0.34) | ($1.04) | $241.64 million | $191.72 million | View | N/A | |
| 5/12/2014 | Q314 | $0.01 | ($0.84) | $256.85 million | $210.80 million | View | Listen | |
| 2/5/2014 | Q214 | $1.08 | $1.08 | $416.60 million | $418.00 million | View | Listen | |
| 10/30/2013 | Q114 | $0.15 | $0.22 | $342.13 million | $343.60 million | View | Listen | |
| 8/8/2013 | Q4 2013 | $0.33 | $0.10 | $289.86 million | $267.60 million | View | Listen | |
| 5/2/2013 | Q3 2013 | $0.02 | $0.02 | $261.31 million | $264.50 million | View | Listen | |
| 1/31/2013 | Q2 2013 | $1.63 | $1.58 | $492.30 million | $468.00 million | View | Listen | |
| 11/5/2012 | Q113 | $0.42 | $0.44 | $336.26 million | $344.50 million | View | N/A | |
| 8/9/2012 | | $0.20 | $0.28 | | | View | N/A | |
| 5/3/2012 | | $0.04 | $0.07 | | | View | N/A | |
| 2/2/2012 | | $1.39 | $1.42 | | | View | N/A | |
| 11/3/2011 | | $0.28 | $0.31 | | | View | N/A | |
| 8/11/2011 | | $0.12 | $0.18 | | | View | N/A | |
| 4/28/2011 | | ($0.06) | $0.02 | | | View | N/A | |
| 2/3/2011 | | $1.04 | $1.20 | | | View | N/A | |
(Data available from 1/1/2011 forward)
Earnings Estimates for Elizabeth Arden (NASDAQ:RDEN)2017 EPS Consensus Estimate: ($0.80)
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|
| Q1 2017 | 2 | ($0.46) | $0.06 | ($0.20) |
| Q2 2017 | 2 | $0.29 | $0.30 | $0.30 |
| Q3 2017 | 1 | ($0.47) | ($0.47) | ($0.47) |
| Q4 2017 | 2 | ($0.59) | ($0.25) | ($0.42) |
| Q1 2018 | 1 | $0.28 | $0.28 | $0.28 |
| Q2 2018 | 1 | $0.56 | $0.56 | $0.56 |
| Q3 2018 | 1 | ($0.31) | ($0.31) | ($0.31) |
(Data provided by Zacks Investment Research)
Dividend History for Elizabeth Arden (NASDAQ:RDEN)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading and Institutional Ownership History for Elizabeth Arden (NASDAQ:RDEN)Insider Ownership Percentage: 15.20%
Institutional Ownership Percentage: 70.70%
Insider Trades by Quarter for Elizabeth Arden (NASDAQ:RDEN)| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Details |
|---|
| 3/3/2016 | Eric Lauzat | Insider | Buy | 5,000 | $6.00 | $30,000.00 | |
| 12/7/2015 | E Scott Beattie | CEO | Sell | 27,000 | $10.91 | $294,570.00 | |
| 12/4/2014 | Oscar E Marina | EVP | Sell | 7,081 | $17.28 | $122,359.68 | |
| 11/24/2014 | E Scott Beattie | CEO | Sell | 25,000 | $18.03 | $450,750.00 | |
| 10/24/2014 | Rhone Capital L.L.C. | Major Shareholder | Buy | 19,200 | $16.81 | $322,752.00 | |
| 10/23/2014 | Rhone Capital L.L.C. | Major Shareholder | Buy | 72,274 | $16.97 | $1,226,489.78 | |
| 10/13/2014 | Rhone Capital L.L.C. | Major Shareholder | Buy | 120,912 | $17.00 | $2,055,504.00 | |
| 10/7/2014 | Rhone Capital L.L.C. | Major Shareholder | Buy | 149,443 | $16.96 | $2,534,553.28 | |
| 10/6/2014 | Rhone Capital L.L.C. | Major Shareholder | Buy | 29,744 | $16.98 | $505,053.12 | |
| 11/27/2013 | Joel Ronkin | EVP | Sell | 20,000 | $39.39 | $787,800.00 | |
| 11/21/2013 | Joel Ronkin | EVP | Sell | 1,759 | $38.03 | $66,894.77 | |
| 9/23/2013 | Dirk Trappmann | EVP | Sell | 7,666 | $34.76 | $266,470.16 | |
| 9/20/2013 | Hoy Heise | EVP | Sell | 8,000 | $35.32 | $282,560.00 | |
| 8/26/2013 | Joel Ronkin | EVP | Sell | 3,600 | $35.43 | $127,548.00 | |
| 6/17/2013 | Stephen J Smith | CFO | Sell | 16,900 | $48.00 | $811,200.00 | |
| 6/5/2013 | Hoy Heise | EVP | Sell | 8,240 | $46.34 | $381,841.60 | |
| 5/17/2013 | Oscar E Marina | EVP | Sell | 15,000 | $48.63 | $729,450.00 | |
| 5/8/2013 | Pierre Pirard | EVP | Sell | 7,134 | $44.00 | $313,896.00 | |
| 8/9/2012 | Oscar E Marina | VP | Sell | 6,600 | $46.25 | $305,250.00 | |
| 8/9/2012 | Richard C W Mauran | Director | Sell | 73,675 | $46.69 | $3,439,885.75 | |
(Data available from 1/1/2013 forward)
Headline Trends for Elizabeth Arden (NASDAQ:RDEN)
Latest Headlines for Elizabeth Arden (NASDAQ:RDEN)
| Source: |
|
| Date | Headline |
|---|
 | Reviewing Coty (COTY) and Elizabeth Arden (RDEN)
www.americanbankingnews.com - July 24 at 9:56 AM |
| Elizabeth Arden (NASDAQ:RDEN) versus Coty (COTY) Critical Survey
www.americanbankingnews.com - July 24 at 12:05 AM |
| Contrasting Elizabeth Arden (NASDAQ:RDEN) & Inter Parfums (IPAR)
www.americanbankingnews.com - July 18 at 9:40 AM |
| Coty (COTY) & Elizabeth Arden (NASDAQ:RDEN) Head-To-Head Review
www.americanbankingnews.com - July 16 at 10:28 PM |
| Head to Head Survey: Elizabeth Arden (NASDAQ:RDEN) vs. Inter Parfums (IPAR)
www.americanbankingnews.com - July 11 at 8:26 PM |
| Comparing Elizabeth Arden (RDEN) & Inter Parfums (IPAR)
www.americanbankingnews.com - June 28 at 6:28 PM |
| Comparing Inter Parfums (IPAR) and Elizabeth Arden (RDEN)
www.americanbankingnews.com - June 25 at 4:06 PM |
| Elizabeth Arden (RDEN) versus Inter Parfums (IPAR) Financial Analysis
www.americanbankingnews.com - June 23 at 8:40 AM |
| Elizabeth Arden (RDEN) and Edgewell Personal Care (EPC) Head to Head Survey
www.americanbankingnews.com - June 19 at 8:08 AM |
| Contrasting Energizer Holdings (EPC) & Elizabeth Arden (RDEN)
www.americanbankingnews.com - June 17 at 6:22 PM |
| Head to Head Survey: DS Healthcare Group (DSKX) & Elizabeth Arden (RDEN)
www.americanbankingnews.com - June 16 at 12:30 PM |
| Head to Head Contrast: DS Healthcare Group (DSKX) versus Elizabeth Arden (RDEN)
www.americanbankingnews.com - June 15 at 12:32 PM |
| Comparing Nu Skin Enterprises (NUS) & Elizabeth Arden (RDEN)
www.americanbankingnews.com - June 7 at 8:12 AM |
 | Revlon appoints Chris Peterson CFO, effective immediately
www.marketwatch.com - June 6 at 8:54 PM |
 | Revlon (REV) CFO to Retire
www.streetinsider.com - June 6 at 8:54 PM |
 | Billionaire financier Ron Perelman ups stake in Revlon amid soft sales
www.bizjournals.com - June 1 at 9:03 PM |
 | Revlon Can Double From Here
seekingalpha.com - May 15 at 6:43 PM |
 | Decline In Sales In The The Brick-And-Mortar Beauty Stores In North America Led To Revlon's Disappointing Quarterly Performance
www.nasdaq.com - May 8 at 6:49 PM |
 | BRIEF-Revlon reports qtrly loss per share of $0.71
www.businessinsider.com - May 6 at 7:18 PM |
| Favorable News Coverage Very Likely to Impact Elizabeth Arden (RDEN) Stock Price
www.americanbankingnews.com - May 3 at 8:56 PM |
| Elizabeth Arden (RDEN) Earns Daily Media Sentiment Score of 0.40
www.americanbankingnews.com - April 22 at 12:32 PM |
 | Revlon to Release First Quarter 2017 Results and Host a Conference Call on May 5, 2017
www.businesswire.com - April 21 at 7:16 PM |
| Elizabeth Arden (RDEN) Earning Favorable Media Coverage, Study Shows
www.americanbankingnews.com - April 16 at 2:15 PM |
| Elizabeth Arden (RDEN) Getting Somewhat Positive Media Coverage, Report Finds
www.americanbankingnews.com - April 13 at 8:14 PM |
 | BRIEF-Revlon names Serge Jureidini as president, Elizabeth Arden & Fragrances
www.reuters.com - March 14 at 6:56 PM |
 | Revlon Swings to Loss Amid Turnaround Effort
www.wsj.com - March 3 at 7:33 PM |
| [$$] Revlon Swings to Loss Amid Turnaround Effort
www.wsj.com - March 3 at 7:33 PM |
| Revlon teams up with Amazon on heels of 'Love Project'
www.bizjournals.com - February 27 at 4:18 PM |
 | Revlon Is Advertising on Amazon Boxes
www.bloomberg.com - February 23 at 7:35 PM |
 | HSN, Inc. Reports Fourth Quarter and Full Year 2016 Results
finance.yahoo.com - February 22 at 9:31 AM |
| Revlon to Release Fourth Quarter 2016 Results and Host a Conference Call on March 3, 2017
www.businesswire.com - February 22 at 9:31 AM |
| Revlon Corp.: Will This Sleeping Giant Come Back To Life?
seekingalpha.com - February 10 at 10:20 PM |
| Revlon Announces Linda Wells to Join Company as Chief Creative Officer
www.businesswire.com - February 9 at 11:04 PM |
| Perry Ellis Int'l (PERY) Names David Rattner as CFO
www.streetinsider.com - February 6 at 7:34 PM |
 | Why Revlon Inc Stock Gained 15% in January
www.fool.com - February 6 at 12:18 AM |
| Why I Feel Bearish On Revlon
seekingalpha.com - January 18 at 8:07 PM |
| Revlon, Inc. (REV)
seekingalpha.com - January 17 at 12:19 PM |
 | [$$] Revlon's Beautiful Outlook
www.barrons.com - January 14 at 5:30 AM |
| Global Fragrances and Perfumes - Merchandising
finance.yahoo.com - January 4 at 9:12 PM |
| Celebrity Designer Hutton Wilkinson and Tony Duquette, Inc. File Copyright Infringement and Unfair Competition …
finance.yahoo.com - December 16 at 9:01 PM |
| CFO Moves: Anixter International, Rapid7, HSN - CFO Journal. - WSJ - Wall Street Journal (blog)
blogs.wsj.com - November 30 at 7:38 PM |
| Perfumes Market: Global Industry Analysis and Opportunity Assessment, 2016 - 2026
finance.yahoo.com - November 29 at 1:51 PM |
Elizabeth Arden (RDEN) Chart for Wednesday, July, 26, 2017
